[Retracted] Network Pharmacology Prediction: The Possible Mechanisms of Cinobufotalin against Osteosarcoma

Table 2

KEGG pathway of the potential therapeutic targets.

Serial number	Term	Count	value	FDR
hsa05200	Pathways in cancer	52	8.80-34	8.18-32
hsa05161	Hepatitis B	35	7.47-31	3.47-29
hsa04210	Apoptosis	25	1.04-27	3.23-26
hsa05205	Proteoglycans in cancer	29	6.79-19	1.58-17
hsa04668	TNF signaling pathway	23	1.18-18	2.20-17
hsa05210	Colorectal cancer	19	2.58-18	4.00-17
hsa05145	Toxoplasmosis	22	3.92-17	5.20-16
hsa05142	Chagas disease (American trypanosomiasis)	21	2.03-16	2.36-15
hsa05222	Small cell lung cancer	19	1.32-15	1.36-14
hsa04064	NF-kappa B signaling pathway	18	3.49-14	3.25-13
hsa04620	Toll-like receptor signaling pathway	19	7.66-14	6.42-13
hsa05152	Tuberculosis	23	8.29-14	6.42-13
hsa04932	Nonalcoholic fatty liver disease (NAFLD)	21	3.75-13	2.69-12
hsa05133	Pertussis	16	8.68-13	5.77-12
hsa05219	Bladder cancer	13	1.40-12	8.68-12
hsa04115	p53 signaling pathway	15	2.78-12	1.62-11
hsa04621	NOD-like receptor signaling pathway	14	4.14-12	2.25-11
hsa05160	Hepatitis C	19	4.36-12	2.25-11
hsa05164	Influenza A	21	5.62-12	2.75-11
hsa04722	Neurotrophin signaling pathway	18	8.52-12	3.96-11

KEGG: Kyoto Encyclopedia of Genes and Genomes; FDR: false discovery rate.